The Contrast Enhanced Ultrasound Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Contrast Enhanced Ultrasound Market:
https://www.thebusinessresearchcompany.com/report/contrast-enhanced-ultrasound-global-market-report
According to The Business Research Company’s Contrast Enhanced Ultrasound Global Market Report 2024, The contrast enhanced ultrasound market size has grown strongly in recent years. It will grow from $1.93 billion in 2023 to $2.05 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to diagnostic accuracy and sensitivity, non-invasiveness and safety, rising incidence of liver diseases, global increase in aging population, growing preference for non-radiation techniques.
The contrast enhanced ultrasound market size is expected to see strong growth in the next few years. It will grow to $2.54 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in cardiovascular diseases, increasing applications in pediatric imaging, expanding role in gastrointestinal imaging, growing focus on precision medicine, integration with artificial intelligence. Major trends in the forecast period include continued technological innovations, advancements in ultrasound technology, expanding applications in oncology, integration with multimodal imaging, real-time quantitative assessment, pediatric applications.
The rising prevalence of chronic diseases is expected to propel the growth of the contrast-enhanced ultrasound market going forward. Chronic diseases refer to long-term medical conditions that persist over an extended period and require ongoing medical management and care. Contrast-enhanced ultrasound helps provide real-time, detailed images of various chronic diseases, such as liver cirrhosis or vascular diseases associated with hypertension, contributing to more effective long-term management. For instance, in January 2023, according to a report published by the National Library of Medicine, a US-based agency, the number of individuals aged 50 years and older having one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Therefore, the rising prevalence of chronic diseases will drive the growth of the contrast-enhanced ultrasound market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13407&type=smp
The contrast enhanced ultrasound market covered in this report is segmented –
1) By Product: Equipment, Contrast Agent
2) By Technology: Non-targeted, Targeted
3) By Application: Hospitals, Clinics, Other Applications
Major companies operating in the contrast-enhanced ultrasound market are developing advanced technologies, such as super-resolution contrast-enhanced ultrasound (CEUS) technology, to improve the spatial resolution of CEUS images. The integration of advanced technologies in contrast-enhanced ultrasound enhances diagnostic capabilities, enabling healthcare professionals to obtain more detailed and accurate information about the anatomy, function, and perfusion of tissues and organs. For instance, in September 2023, Philips, a Netherlands-based company that develops and manufactures medical systems and consumer electronics products, launched Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS), a super-resolution CEUS technology that uses advanced signal processing algorithms to improve the spatial resolution of CEUS images. It helps to provide high-resolution images of blood vessels and other structures to diagnose and treat a variety of diseases, including cancer, liver disease, and vascular diseases.
The contrast enhanced ultrasound market report table of contents includes:
1. Executive Summary
2.Contrast Enhanced Ultrasound Market Characteristics
3.Contrast Enhanced Ultrasound Market Trends And Strategies
4.Contrast Enhanced Ultrasound Market analysis
5.Contrast Enhanced Ultrasound Market Size And Growth
6.Contrast Enhanced Ultrasound Segmentation
7.Contrast Enhanced Ultrasound Regional And Country Analysis
.
.
.
27.Contrast Enhanced Ultrasound Competitive Landscape And Company Profiles
28.Contrast Enhanced Ultrasound Key Mergers And Acquisitions
29.Contrast Enhanced Ultrasound Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- General Electric Company
- Bayer AG
- Bristol-Myers Squibb Company
- Siemens Healthcare GmbH
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Global Contrast Enhanced Ultrasound Market: OverviewThe advent of economical contrast agents, contrast imaging modes, and increased volume of ultrasound procedures are becoming an important part of ultrasound systems are all contributing to the expansion of the global contrast enhanced ultrasound market.
In the battle against COVID-19, the necessity of using CEUS technology into point-of-care (PoC) diagnostics has been a significant learning.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=83131 The global contrast enhanced ultrasound market is expected to benefit from the rising prevalence of complicated comorbidities and long-term illnesses.
In addition to that, technological improvements in contrast-enhanced ultrasound imaging, and private and government sector investments are likely to augur well for the market in the years to come.
The importance of these tests in determining the necessity for treatment/surgery during perioperative scans and interventional procedures prior to operations is expected to increase the use of contrast media in imaging techniques.Transparency Market Research offers a comprehensive understanding of the global Contrast Enhanced Ultrasound market through this report.
It offers well-researched data on various facets of the market to offer valuable business input for profit generation.Request COVID Analysis on Contrast Enhanced Ultrasound Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=83131 Global Contrast Enhanced Ultrasound Market: Notable DevelopmentsSiemens Healthineers introduced the Acuson Sequoia ultrasound system in June 2018, which offers high-resolution imaging that adapts to individuals' personal traits for improved diagnosis.
However, the high cost of contrast-enhanced ultrasound equipment and the scarcity of helium may cause the industry to shrink dramatically.Pre Book Contrast Enhanced Ultrasound Market Report- https://www.transparencymarketresearch.com/checkout.php?rep_id=83131=S Global Contrast Enhanced Ultrasound Market: Geographical AnalysisBecause of the growing incidence of lifestyle-related chronic illnesses and the widespread use of ultrasonography in general diagnostics, North America is likely to dominate the market and is projected to do so for a few more years.
